Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Allopurinol for chronic prostatitis.

C O McNaughton1, T Wilt

  • 1General Internal Medicine (111-0), Minneapolis VA/VISN 13 Center for Chronic Disease Outcomes Research, One Veterans Drive, Minneapolis, Minnesota 55417, USA. MACDONALD.RODERICK@minneapolis.va.gov

The Cochrane Database of Systematic Reviews
|January 10, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adjuvant hormone therapy for localised and locally advanced prostate carcinoma: a systematic review and meta-analysis of randomised trials.

Cancer treatment reviews·2009
Same author

A systematic review and meta-analysis of randomised trials of neo-adjuvant hormone therapy for localised and locally advanced prostate carcinoma.

Cancer treatment reviews·2008
Same author

Targeted therapy for advanced renal cell carcinoma.

The Cochrane database of systematic reviews·2008
Same author

Bisphosphonates for advanced prostate cancer.

The Cochrane database of systematic reviews·2006
Same author

Screening for prostate cancer.

The Cochrane database of systematic reviews·2006
Same author

Immunotherapy for advanced renal cell cancer.

The Cochrane database of systematic reviews·2005
Same journal

Interventions to prevent or cease electronic cigarette use in children and adolescents.

The Cochrane database of systematic reviews·2026
Same journal

Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).

The Cochrane database of systematic reviews·2026
Same journal

Interventions for smoking cessation in inpatient psychiatry settings.

The Cochrane database of systematic reviews·2026
Same journal

Mechanical thromboprophylaxis for preventing intradialytic hypotension in people undergoing maintenance haemodialysis.

The Cochrane database of systematic reviews·2026
Same journal

Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit.

The Cochrane database of systematic reviews·2026
Same journal

Views and experiences of weight management for people living with mobility‑limiting conditions, intellectual disabilities or severe mental illness: a qualitative evidence synthesis.

The Cochrane database of systematic reviews·2026
See all related articles

Allopurinol may effectively treat chronic prostatitis by reducing patient discomfort and prostate pain. This study found significant symptom improvement with allopurinol compared to placebo, though further research is needed.

Area of Science:

  • Urology
  • Pharmacology
  • Clinical Trials

Background:

  • Chronic prostatitis causes significant morbidity, including urinary symptoms, sexual dysfunction, and pelvic pain.
  • The etiology of chronic prostatitis remains unknown, leading to varied treatment approaches.
  • A novel theory suggests urine reflux into prostatic ducts causes inflammation due to high metabolite concentrations, prompting investigation of allopurinol.

Purpose of the Study:

  • To evaluate the efficacy of allopurinol in treating chronic prostatitis.
  • To assess the impact of allopurinol on patient-reported discomfort and pain.

Main Methods:

  • Systematic search of randomized controlled trials comparing allopurinol to placebo for chronic prostatitis.
  • Exclusion of acute, bacterial, and asymptomatic prostatitis.

Related Experiment Videos

  • Primary outcome measure: change in patient-reported discomfort; secondary outcomes: prostate pain, leukocyte counts, biochemical indices.

    • Main Results:

    • One trial involving 54 men met inclusion criteria.
    • Allopurinol significantly improved patient-reported discomfort and investigator-graded prostate pain compared to placebo.
    • Allopurinol reduced serum and prostatic urate levels; no significant side effects were noted.

    Conclusions:

    • A single trial suggests allopurinol may improve symptoms and biochemical markers in chronic prostatitis.
    • The current evidence is not fully convincing due to trial limitations.
    • Further studies with standardized outcomes are necessary to confirm allopurinol's effectiveness.